Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Eugenio Milano
Observed names:
E Milano,
E. Milano,
Milano Eugenio,
Milano, Eugenio
Institutions:
Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari,
University of Bari Aldo Moro
Observed institutions:
University of Rome Tor Vergata,
University of Milan,
Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani,
Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari,
Istituti di Ricovero e Cura a Carattere Scientifico,
University of Bari Aldo Moro
show all 6
ORCID:
0000-0002-6113-223X
Observed ORCID:
0000-0002-6113-223X
OpenAlex ID:
A5007410854
Human Monkeypox: A Comprehensive Narrative Review and Analysis of the Public Health Implications
2022
·
Francesco Di Gennaro
, Nicola Veronese
, et al.
·
Microorganisms
·
94
PDF
Varicella-Zoster Virus Reactivation and Increased Vascular Risk in People Living with HIV: Data from a Retrospective Cohort Study
2023
·
Deborah Fiordelisi
, Mariacristina Poliseno
, et al.
·
Viruses
·
39
PDF
Immunogenicity and safety of the BNT162b2 COVID‐19 mRNA vaccine in PLWH: A monocentric study in Bari, Italy
2022
·
Eugenio Milano
, Aurelia Ricciardi
, et al.
·
Journal of Medical Virology
·
39
HCV and diabetes: towards a ‘sustained’ glycaemic improvement after treatment with DAAs?
2016
·
C. Fabrizio
, A. Procopio
, et al.
·
Clinical Microbiology and Infection
·
29
PDF
HCV mono-infected and HIV/HCV co-infected individuals treated with direct-acting antivirals: to what extent do they differ?
2017
·
Giuseppe Bruno
, Annalisa Saracino
, et al.
·
International Journal of Infectious Diseases
·
24
PDF
Effectiveness and predictors of treatment discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona Cohort
2025
·
Roberta Gagliardini
, Sara De Benedittis
, et al.
·
Journal of Antimicrobial Chemotherapy
·
22
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort
2019
·
Lucia Taramasso
, Patrizia Lorenzini
, et al.
·
Journal of Antimicrobial Chemotherapy
·
19
PDF
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort
2024
·
Antonella d’Arminio Monforte
, Alessandro Tavelli
, et al.
·
Journal of Antimicrobial Chemotherapy
·
15
PDF
Gp120 substitutions at positions associated with resistance to fostemsavir in treatment-naive HIV-1-positive individuals
2020
·
Luciana Lepore
, Claudia Fabrizio
, et al.
·
Journal of Antimicrobial Chemotherapy
·
15
Loa loa in the Vitreous Cavity of the Eye: A Case Report and State of Art
2022
·
Elisabetta Pallara
, Sergio Cotugno
, et al.
·
American Journal of Tropical Medicine and Hygiene
·
14
PDF
Anti‐spike S1 receptor‐binding domain antibodies against SARS‐CoV‐2 persist several months after infection regardless of disease severity
2021
·
Davide F. Bavaro
, Paola Laghetti
, et al.
·
Journal of Medical Virology
·
14
PDF
First Case of Paraphimosis as a Severe Complication of Monkeypox
2022
·
Eugenio Milano
, Alessandra Belati
, et al.
·
Vaccines
·
12
PDF
Phylogeography and genomic epidemiology of SARS-CoV-2 in Italy and Europe with newly characterized Italian genomes between February-June 2020
2022
·
Alessia Lai
, Annalisa Bergna
, et al.
·
Scientific Reports
·
12
PDF
Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study
2023
·
Antonella D’arminio Monforte
, Alessandro Tavelli
, et al.
·
Journal of Antimicrobial Chemotherapy
·
11
PDF
The elderly and direct antiviral agents: Constraint or challenge?
2017
·
Claudia Fabrizio
, Annalisa Saracino
, et al.
·
Digestive and Liver Disease
·
11
Safety and effectiveness of a 12-week course of sofosbuvir and simeprevir ± ribavirin in HCV-infected patients with or without HIV infection: a multicentre observational study
2017
·
Giuseppe Bruno
, Annalisa Saracino
, et al.
·
International Journal of Antimicrobial Agents
·
11
DAA-Based Treatment for HIV–HCV-Coinfected Patients: Analysis of Factors of Sustained Virological Response in a Real-Life Study
2019
·
Loredana Alessio
, Lorenzo Onorato
, et al.
·
Antiviral Therapy
·
9
Real life experience on the use of Remdesivir in patients admitted to COVID-19 in two referral Italian hospital: a propensity score matched analysis
2024
·
Nicola Veronese
, Francesco Di Gennaro
, et al.
·
Scientific Reports
·
8
PDF
Virological response and retention in care according to time of starting ART in Italy: data from the Icona Foundation Study cohort
2019
·
Antonella d’Arminio Monforte
, Alessandro Tavelli
, et al.
·
Journal of Antimicrobial Chemotherapy
·
8
PDF
Implementation of HIV pre-exposure prophylaxis (PrEP) in Italy (2023-2024): Results from the PrIDE cohort survey
2026
·
Silvia Nozza
, Thomas Masoero
, et al.
·
International Journal of Infectious Diseases
·
7
PDF
Brief Report: New HIV Diagnoses in PrEP-Experienced and PrEP-Naive Persons in the ICONA Cohort
2024
·
Lucia Taramasso
, Roberto Rossotti
, et al.
·
JAIDS Journal of Acquired Immune Deficiency Syndromes
·
7
OC-50 Implementation of PrEP in Italy: results of PrIDE survey
2024
·
S Nozza
, V Mazzotta
, et al.
·
Sexually Transmitted Infections
·
7
PDF
HPV and Covid-19 Era: effects of nonpharmaceutical interventions on HPV transmission
2023
·
Ronga Luigi
, Stolfa Stefania
, et al.
·
Pathogens and Global Health
·
7
PDF
HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients
2020
·
Vincenzo Malagnino
, Carlotta Cerva
, et al.
·
Open Forum Infectious Diseases
·
7
PDF
Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort
2025
·
Alessandra Vergori
, Alessandro Cozzi-Lepri
, et al.
·
Journal of Antimicrobial Chemotherapy
·
4
Show more works
View as search
Works count:
41
Citation count:
454
H-index:
12
I10-index:
16
Year
Topic
Type